Expert InsightsPredicting drug responses using pancreatic cancer organoids and multimodal plate imaging: Your questions answered
Industry NewsFDA authorizes first tests that estimate a patient’s antibodies from past SARS-CoV-2 infection
Industry NewsAkoya Biosciences collaborates with leading cancer center to discover predictive biomarkers for cancer
Industry NewsHorizon Discovery licenses CHOSOURCE platform to TrueBinding for development and commercialization of multiple biotherapeutics
Product NewsFDA approves Roche’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy
Product NewsThermo Scientific nProber IV delivers faster, easier failure analysis process for semiconductor labs